The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells
Open Access
- 1 October 2009
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 147 (2) , 185-191
Abstract
Summary: Allogeneic hematopoietic cell transplantation can be curative for patients with high‐risk acute leukaemia. Umbilical cord blood (UCB) is an increasingly used source of allogeneic stem cells for patients who are in need of a transplant, but do not have a sibling donor. This review highlights the similarities and differences between the natural killer (NK) cells obtained from adult peripheral blood (PB) and UCB. These two cell sources show similar percentages of NK cells, including the major CD56dim and CD56bright subpopulations. UCB also contains an additional CD56−CD16+ subset, not typically found in PB. In addition, there are a number of progenitor cell populations in UCB that can give rise to NK cells. Some studies showed that UCB NK cells express a relatively higher percentage of inhibitory receptors (CD94/NKG2A and killer‐cell immunoglobulin‐like receptors) and less adhesion molecules. Resting UCB NK cells also show significantly less cytotoxicity compared to PB NK cells. However, following cytokine stimulation, the cytotoxicity of UCB NK cells can be rapidly increased to levels that are comparable to PB NK cells. Activation and expansion protocols for UCB NK cells are briefly reviewed. Lastly, we outline the early use of UCB NK cells in clinical trials.Keywords
This publication has 53 references indexed in Scilit:
- CD16+ CD56− NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft‐versus‐leukemia effectEuropean Journal of Haematology, 2008
- Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15Experimental Hematology, 2008
- Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison studyThe Lancet, 2007
- Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cellsBlood, 2006
- Effect of IL-21 on NK cells derived from different umbilical cord blood populationsInternational Immunology, 2005
- Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsBlood, 2005
- Interleukin-15 Enhances Cytotoxicity, Receptor Expression, and Expansion of Neonatal Natural Killer Cells in Long-Term CultureClinical and Vaccine Immunology, 2004
- A novel myeloid-like NK cell progenitor in human umbilical cord bloodBlood, 2003
- Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantationBone Marrow Transplantation, 1999
- Two different maturational stages of natural killer lymphocytes in human newborn infantsThe Journal of Pediatrics, 1991